Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.
from RSS Feeds : RSS Feed - NDTV Gadgets360.com https://ift.tt/2XjoJ5n
via IFTTT
from RSS Feeds : RSS Feed - NDTV Gadgets360.com https://ift.tt/2XjoJ5n
via IFTTT
Comments
Post a Comment